Amit Vora1. 1. Green-gagan, Lokhandwala Township, Kandivli (East), Mumbai, Maharashtra, India. amvora@hotmail.com
Abstract
PURPOSE OF REVIEW: Atrial fibrillation in patients with rheumatic valvular heart disease results in significant morbidity and possibly mortality. RECENT DEVELOPMENTS: The recent advances in treatment options for non-rheumatic atrial fibrillation have widened its scope of management. These treatment modalities have not been extensively validated in rheumatic valvular heart disease. SUMMARY: A review and comparison of the available data in atrial fibrillation and rheumatic valvular heart disease vis-à-vis non-rheumatic atrial fibrillation is presented.
PURPOSE OF REVIEW: Atrial fibrillation in patients with rheumatic valvular heart disease results in significant morbidity and possibly mortality. RECENT DEVELOPMENTS: The recent advances in treatment options for non-rheumatic atrial fibrillation have widened its scope of management. These treatment modalities have not been extensively validated in rheumatic valvular heart disease. SUMMARY: A review and comparison of the available data in atrial fibrillation and rheumatic valvular heart disease vis-à-vis non-rheumatic atrial fibrillation is presented.